Elmiron Investigation

ELMIRON INVESTIGATION Squitieri & Fearon, LLP is investigating claims on behalf of people who took Elmiron, a prescription drug used to treat bladder pain and discomfort associated with interstitial cystitis (IC).  Elmiron has come under fire for its link to serious eye damage. Approved by the U.S. Food and Drug Administration (FDA) in 1996, pentosan more »

Zoom Video Communications, Inc. Investigation

ZOOM VIDEO COMMUNICATIONS, INC. INVESTIGATION Squitieri & Fearon, LLP is investigating claims that the directors and executive officers of Zoom Video Communications, Inc., knew but failed, throughout 2019 and early 2020,  to disclose material information about  security deficiencies in its systems and protocols until March and April 2020. When such information was revealed, Zoom’s stock more »

Allianz Life Insurance Investigation

ALLIANZ LIFE INSURANCE INVESTIGATION Squitieri & Fearon, LLP is investigating claims that Allianz, through its life insurance subsidiary operations in the United States sold policies through its agents whose premiums were financed through investments in Future Income Products (“FIP”) that Allianz’s agents sold to clients along with the Allianz life insurance. When FIP collapsed amidst more »

Schools, Colleges and Universities’ Tuition, Room & Board Charges Under Investigation

SCHOOLS, COLLEGES AND UNIVERSITIES’ TUITION, ROOM & BOARD CHARGES UNDER INVESTIGATION Squitieri & Fearon, LLP is investigating claims for a possible class action on behalf of students, families and guardians who paid tuition, room and board and other fees for the Spring 2020 academic semester at any education institutions, and who—because of that institution’s response more »

Air Canada Failure To Refund Purchase Price Investigation

AIR CANADA FAILS TO REFUND PURCHASE PRICE Squitieri & Fearon, LLP is investigating claims on behalf of customers who were denied a refund after their flight on Air Canada was cancelled due to the COVID-19 pandemic. Recently, travelers have reported that Air Canada has denied their requests for refunds and has instead forced customers to accept more »

Fifth Third Bancorp Shareholder Investigation

Fifth Third Bancorp Shareholder Investigation Into Management Misconduct And The Stock Drop Squitieri & Fearon, LLP is investigating claims that the Board of Directors and officers of  Fifth Third Bancorp (NASDAQ: FITB) were derelict in their duties in allowing employees to corruptly cross-sell services to Fifth Third’s existing account holders by signing them up for more »

Zuora, Inc. Investigation

Zuora, Inc. Investigation Squitieri & Fearon, LLP  is investigating claims that officers and directors of Zuora, Inc. (NYSE:ZUO) covered up problems in its integration of a 2018 acquisition and allowed investors to purchase Zuora stock at inflated prices from 2018 through May 2019. In May 2019, Zuora was forced to admit the problems and reveal more »

Costco Square Trade Protection Plan Class Action

Costco Square Trade Protection Plan Class Action Squitieri & Fearon, LLP is investigating claims that Costco sells its Square Trade Protection Plan to customers who buy televisions, tablets, cameras, computers and major appliances even though the warranties from the Protection Plan expire before some of the manufacturers’ warranties. The allegation is that Costco is selling more »

Just For Men Investigation

Squitieri & Fearon, LLP is investigating claims against Just for Men hair dye maker Combe, Inc. A class action lawsuit was filed on January 25, 2017 accusing Just for Men hair dye maker Combe, Inc., and other Combe companies, of deceptive advertising.  The complaint alleges that Just for Men brand hair dye does not properly more »

Aetna CVS Inflated Stock Price Investigation

Squitieri & Fearon, LLP is investigating possible claims for participants in the Aetna 401(k) Plan who received CVS stock when CVS acquired Aetna in November 2018. We are investigating claims for participants in the Aetna 401(k) Plan who had invested in Aetna stock through the plan and whose Aetna stock was converted into CVS stock when more »